Ipilimumab (anti-CTLA-4)

Product Name：Ipilimumab biosimilar

CAS No.:   477202-00-9                              

Formula:   C₆₇₄₂H₉₉₇₂N₁₇₃₂O₂₀₀₄S₄₀                          

Molecular Weight：  148 kDa                  

Type:    Whole antibody                      

Target：  CTLA-4
Antibody Form:  Purified immunoglobulin
Physical Form:  Solution
Storage:  -70±15℃ for long-term storage, 2-8℃ for short-term storage, away from light.

Description

Ipilimumab biosimilaris a recombinant, human monoclonal antibody that binds to the cytotoxic T-lymphocyte-associated antigen 4 (CTLA-4). Ipilimumab  biosimilar is an IgG1 kappa immunoglobulin with an approximate molecular weight of 148 kDa. Ipilimumab biosimilar is produced in mammalian (Chinese hamster ovary) cell culture.

Biological Activity
Ipilimumab (anti-CTLA-4) is an immunomodulatory monoclonal antibody directed against the cell surface antigen CTLA-4 and also a type of immune checkpoint 

For research use only. Not for use in humans